Literature DB >> 18337266

Improving the evidence base for treatment of juvenile idiopathic arthritis: the challenge and opportunity facing the MCRN/ARC Paediatric Rheumatology Clinical Studies Group.

J Thornton, M W Beresford, P Clayton.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18337266     DOI： 10.1093/rheumatology/ken055

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  3 in total

Review 1.  Juvenile idiopathic arthritis: new insights into classification, measures of outcome, and pharmacotherapy.

Authors:  Michael W Beresford
Journal:  Paediatr Drugs       Date:  2011-06-01       Impact factor: 3.022

2.  What do young people with rheumatic conditions in the UK think about research involvement? A qualitative study.

Authors:  Suzanne Parsons; Wendy Thomson; Katharine Cresswell; Bella Starling; Janet E McDonagh
Journal:  Pediatr Rheumatol Online J       Date:  2018-05-24       Impact factor: 3.054

3.  Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study.

Authors:  Gerd Horneff; Ruben Burgos-Vargas; Tamas Constantin; Ivan Foeldvari; Jelena Vojinovic; Vyacheslav G Chasnyk; Joke Dehoorne; Violeta Panaviene; Gordana Susic; Valda Stanevica; Katarzyna Kobusinska; Zbigniew Zuber; Richard Mouy; Ingrida Rumba-Rozenfelde; Luciana Breda; Pavla Dolezalova; Chantal Job-Deslandre; Nico Wulffraat; Daniel Alvarez; Chuanbo Zang; Joseph Wajdula; Deborah Woodworth; Bonnie Vlahos; Alberto Martini; Nicolino Ruperto
Journal:  Ann Rheum Dis       Date:  2013-05-21       Impact factor: 19.103
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.